Preladenant (developmental code name SCH-420814) is a drug that was developed by Schering-Plough which acts as a potent and selective antagonist of the adenosine A2A receptor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.